Later, in 2009, a publication revealed that tramiprosate treatments in mild to moderate AD patients showed some beneficial effects, but did not reach statistical significance [ 153 ].
← all excerpts
Drug Development for Alzheimer's Disease: Microglia Induced Neuroinflammation as a Target?
1
—
—